EXACT Historical Income Statement
| EXAS Stock | USD 63.22 0.64 1.00% |
Historical analysis of EXACT Sciences income statement accounts such as Research Development of 447.2 M or Total Operating Expenses of 2.2 B can show how well EXACT Sciences performed in making a profits. Evaluating EXACT Sciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of EXACT Sciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining EXACT Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether EXACT Sciences is a good buy for the upcoming year.
EXACT |
About EXACT Income Statement Analysis
EXACT Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to EXACT Sciences shareholders. The income statement also shows EXACT investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
EXACT Sciences Income Statement Chart
EXACT Sciences Income Statement is one of the three primary financial statements used for reporting EXACT's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of EXACT Sciences revenue and expense. EXACT Sciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, EXACT Sciences' Cost Of Revenue is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 77.9 M in 2024, despite the fact that EBIT is likely to grow to (208.8 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of EXACT Sciences. It is also known as EXACT Sciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from EXACT Sciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into EXACT Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.At this time, EXACT Sciences' Cost Of Revenue is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 77.9 M in 2024, despite the fact that EBIT is likely to grow to (208.8 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Non Recurring | 20.2M | 16.0M | 14.4M | 13.7M | Reconciled Depreciation | 180.3M | 197.6M | 206.6M | 131.5M |
EXACT Sciences income statement Correlations
Click cells to compare fundamentals
EXACT Sciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
EXACT Sciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 61.6M | 96.0M | 18.6M | 19.6M | 24.4M | 25.6M | |
| Other Operating Expenses | 1.1B | 2.0B | 2.6B | 2.7B | 2.7B | 2.8B | |
| Operating Income | (233.8M) | (558.4M) | (835.5M) | (577.5M) | (215.0M) | (204.3M) | |
| Ebit | (233.8M) | (558.4M) | (835.5M) | (577.5M) | (219.7M) | (208.8M) | |
| Research Development | 139.7M | 554.1M | 385.6M | 393.4M | 425.9M | 447.2M | |
| Ebitda | (217.7M) | (465.0M) | (740.5M) | (480.1M) | (13.1M) | (13.8M) | |
| Total Operating Expenses | 893.4M | 1.7B | 2.1B | 2.1B | 2.1B | 2.2B | |
| Net Income | (84.0M) | (848.5M) | (595.6M) | (623.5M) | (204.1M) | (214.4M) | |
| Income Tax Expense | (184.9M) | (8.6M) | (246.9M) | (9.1M) | 2.4M | 2.3M | |
| Depreciation And Amortization | 16.0M | 93.4M | 95.0M | 97.5M | 206.6M | 216.9M | |
| Selling General Administrative | 352.5M | 481.7M | 801.3M | 737.3M | 1.4B | 1.5B | |
| Total Revenue | 876.3M | 1.5B | 1.8B | 2.1B | 2.5B | 2.6B | |
| Gross Profit | 659.6M | 1.1B | 1.3B | 1.5B | 1.8B | 1.9B | |
| Cost Of Revenue | 216.7M | 354.3M | 458.8M | 574.4M | 654.2M | 686.9M | |
| Income Before Tax | (268.9M) | (857.1M) | (842.5M) | (632.6M) | (201.7M) | (211.8M) | |
| Total Other Income Expense Net | (35.1M) | (298.8M) | (7.0M) | (55.0M) | 42.4M | 77.9M | |
| Selling And Marketing Expenses | 385.2M | 589.9M | 861.9M | 846.0M | 203.9M | 217.2M | |
| Net Income From Continuing Ops | (84.0M) | (848.5M) | (595.6M) | (623.5M) | (204.1M) | (214.4M) | |
| Non Operating Income Net Other | 26.5M | 6.9M | 31.8M | (19.4M) | (22.3M) | (21.2M) | |
| Net Income Applicable To Common Shares | (84.0M) | (848.5M) | (595.6M) | (623.5M) | (561.2M) | (533.1M) | |
| Net Interest Income | (61.6M) | (88.0M) | (18.6M) | (19.6M) | (29.8M) | (31.3M) | |
| Tax Provision | (184.9M) | (8.6M) | (246.9M) | (9.1M) | 2.4M | 2.5M | |
| Reconciled Depreciation | 50.2M | 163.4M | 180.3M | 197.6M | 206.6M | 131.5M |
Pair Trading with EXACT Sciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EXACT Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EXACT Sciences will appreciate offsetting losses from the drop in the long position's value.Moving against EXACT Stock
| 0.54 | REGN | Regeneron Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
| 0.53 | HOWL | Werewolf Therapeutics Financial Report 9th of May 2024 | PairCorr |
| 0.48 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.45 | ABBV | AbbVie Inc Financial Report 25th of April 2024 | PairCorr |
| 0.43 | CCCC | C4 TherapeuticsInc Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to EXACT Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EXACT Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EXACT Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling EXACT Sciences to buy it.
The correlation of EXACT Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EXACT Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if EXACT Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EXACT Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.13) | Revenue Per Share 13.876 | Quarterly Revenue Growth 0.17 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.